Back to School: How biopharma can reboot drug development. Access exclusive analysis here
CHIR's peptoid and other chemical diversity technologies will be used with Janssen's medicinal chemistry to create new
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury